These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 17569224)

  • 1. Pharmacokinetics and pharmacodynamics of curcumin.
    Sharma RA; Steward WP; Gescher AJ
    Adv Exp Med Biol; 2007; 595():453-70. PubMed ID: 17569224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin: the story so far.
    Sharma RA; Gescher AJ; Steward WP
    Eur J Cancer; 2005 Sep; 41(13):1955-68. PubMed ID: 16081279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
    Shehzad A; Wahid F; Lee YS
    Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin and neurodegenerative diseases: a perspective.
    Darvesh AS; Carroll RT; Bishayee A; Novotny NA; Geldenhuys WJ; Van der Schyf CJ
    Expert Opin Investig Drugs; 2012 Aug; 21(8):1123-40. PubMed ID: 22668065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects.
    Kotha RR; Luthria DL
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31412624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 427():1-275. PubMed ID: 12616304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer.
    Heger M; van Golen RF; Broekgaarden M; Michel MC
    Pharmacol Rev; 2014; 66(1):222-307. PubMed ID: 24368738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials.
    Strimpakos AS; Sharma RA
    Antioxid Redox Signal; 2008 Mar; 10(3):511-45. PubMed ID: 18370854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
    Jurenka JS
    Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives.
    Tsuda T
    Food Funct; 2018 Feb; 9(2):705-714. PubMed ID: 29206254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, Pharmacodynamics, and PKPD Modeling of Curcumin in Regulating Antioxidant and Epigenetic Gene Expression in Healthy Human Volunteers.
    Cheng D; Li W; Wang L; Lin T; Poiani G; Wassef A; Hudlikar R; Ondar P; Brunetti L; Kong AN
    Mol Pharm; 2019 May; 16(5):1881-1889. PubMed ID: 30860383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
    Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
    Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.
    Sharma RA; McLelland HR; Hill KA; Ireson CR; Euden SA; Manson MM; Pirmohamed M; Marnett LJ; Gescher AJ; Steward WP
    Clin Cancer Res; 2001 Jul; 7(7):1894-900. PubMed ID: 11448902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of curcumin: problems and promises.
    Anand P; Kunnumakkara AB; Newman RA; Aggarwal BB
    Mol Pharm; 2007; 4(6):807-18. PubMed ID: 17999464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups.
    Chen WF; Deng SL; Zhou B; Yang L; Liu ZL
    Free Radic Biol Med; 2006 Feb; 40(3):526-35. PubMed ID: 16443168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose escalation of a curcuminoid formulation.
    Lao CD; Ruffin MT; Normolle D; Heath DD; Murray SI; Bailey JM; Boggs ME; Crowell J; Rock CL; Brenner DE
    BMC Complement Altern Med; 2006 Mar; 6():10. PubMed ID: 16545122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study.
    Sunagawa Y; Hirano S; Katanasaka Y; Miyazaki Y; Funamoto M; Okamura N; Hojo Y; Suzuki H; Doi O; Yokoji T; Morimoto E; Takashi T; Ozawa H; Imaizumi A; Ueno M; Kakeya H; Shimatsu A; Wada H; Hasegawa K; Morimoto T
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(1):37-44. PubMed ID: 25994138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?
    Lopresti AL
    Adv Nutr; 2018 Jan; 9(1):41-50. PubMed ID: 29438458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin: from food spice to cancer prevention.
    Oyagbemi AA; Saba AB; Ibraheem AO
    Asian Pac J Cancer Prev; 2009; 10(6):963-7. PubMed ID: 20192567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the in vitro efficacy, pharmacokinetics and in vivo efficacy of curcumin.
    Bolger GT; Pucaj K; Minta YO; Sordillo P
    Biochem Pharmacol; 2022 Nov; 205():115251. PubMed ID: 36130650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.